Trial intelligence / Profile preview

Ibuprofen Injection for Acute Fever

CTR20160546Phase 3Active

Sponsor
Simcere Pharmaceutical Group
Start
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ibuprofen in febrile infection (AFI), sponsored by Simcere Pharmaceutical Group. Started Aug 2016; status: active.

02

Drugs

ibuprofen
03

Conditions

febrile infection (AFI)

Beyond the preview

Go deeper on CTR20160546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call